The Community for Technology Leaders
RSS Icon
Issue No.06 - Nov.-Dec. (2012 vol.9)
pp: 1595-1606
N. Kazmi , Sch. of Comput., Eng. & Inf. Sci., Northumbria Univ., Newcastle upon Tyne, UK
M. A. Hossain , Sch. of Comput., Eng. & Inf. Sci., Northumbria Univ., Newcastle upon Tyne, UK
R. M. Phillips , Inst. of Cancer Therapeutics, Univ. of Bradford, Bradford, UK
Bioreductive drugs are a class of hypoxia selective drugs that are designed to eradicate the hypoxic fraction of solid tumors. Their activity depends upon a number of biological and pharmacological factors and we used a mathematical modeling approach to explore the dynamics of tumor growth, infusion, and penetration of the bioreductive drug Tirapazamine (TPZ). An in-silico model is implemented to calculate the tumor mass considering oxygen and glucose as key microenvironmental parameters. The next stage of the model integrated extra cellular matrix (ECM), cell-cell adhesion, and cell movement parameters as growth constraints. The tumor microenvironments strongly influenced tumor morphology and growth rates. Once the growth model was established, a hybrid model was developed to study drug dynamics inside the hypoxic regions of tumors. The model used 10, 50 and 100 μM as TPZ initial concentrations and determined TPZ pharmacokinetic (PK) (transport) and pharmacodynamics (cytotoxicity) properties inside hypoxic regions of solid tumor. The model results showed that diminished drug transport is a reason for TPZ failure and recommend the optimization of the drug transport properties in the emerging TPZ generations. The modeling approach used in this study is novel and can be a step to explore the behavioral dynamics of TPZ.
Tumors, Biological system modeling, Drugs, Mathematical model, Electronic countermeasures, Computational modeling,microenvironment and Tirapazamine, Extra cellular matrix, Hypoxia, mathematical modeling
N. Kazmi, M. A. Hossain, R. M. Phillips, "A Hybrid Cellular Automaton Model of Solid Tumor Growth and Bioreductive Drug Transport", IEEE/ACM Transactions on Computational Biology and Bioinformatics, vol.9, no. 6, pp. 1595-1606, Nov.-Dec. 2012, doi:10.1109/TCBB.2012.118
[1] H.M. Byrne, “Using Mathematics to Study Solid Tumour Growth,” Proc. Ninth General Meetings of European Women in Math., pp. 81-107, 1999.
[2] D. Hanahan and R.A. Weinberg, “Hallmarks of Cancer: The Next Generation,” Cell, vol. 144, pp. 646-674, 2011.
[3] K.O. Hicks, F.B. Pruijn, T.W. Secomb, M.P. Hay, R. Hsu, J.M. Brown, W.A. Denny, M.W. Dewhirst, and W.R. Wilson, “Use of Three Dimensional Tissue Cultures to Model Extravascular Transport and Predict in Vivo Activity of Hypoxia-Targeted Anticancer Drugs,” J. Nat'l Cancer Inst., vol. 98, pp. 1118-1128, 2006.
[4] P. Vaupel, “Tumor Microenvironmental Physiology and Its Implications for Radiation Oncology,” Seminars in Radiation Oncology, vol. 14, pp. 198-206, 2004.
[5] J.M. Brown, “Exploiting the Hypoxic Cancer Cell: Mechanisms and Therapeutic Strategies,” Molecular Medicine Today, vol. 6, pp. 157-162, 2000.
[6] J.M. Brown, “SR 4233 (Tirapazamine): A New Anticancer Drug Exploiting Hypoxia in Solid Tumours,” British J. Cancer, vol. 67, pp. 1163-1170, 1993.
[7] J.M. Brown and W.R. Wilson, “Exploiting Tumour Hypoxia in Cancer Treatment,” Nature Rev. Cancer, vol. 4, pp. 437- 447, 2004.
[8] H. Hatzikirou and A. Deutsch, “Cellular Automata as Microscopic Models of Cell Migration in Heterogeneous Environments,” Current Topics in Developmental Biology, vol. 81, 2008.
[9] A.A. Patel, E.T. Gawlinski, S.K. Lemieux, and R.A. Gatenby, “A Cellular Automaton Model of Early Tumor Growth and Invasion: The Effects of Native Tissue Vascularity and Increased Anaerobic Tumor Metabolism,” J. Theoratical Biology, vol. 213, pp. 315-331, 2001.
[10] T.S. Deisboeck, L. Zhang, J. Yoon, and J. Costa, “In Silico Cancer Modeling: Is It Ready for Prime Time?” Nature Rev. Clinical Oncology, vol. 6, pp. 34-42, 2009.
[11] R.P. Araujo and D.L.S. Mcelwain, “A History of the Solid Tumour Growth: The Contribution of Mathematical Modelling,” Bull. Math. Biology, vol. 66, pp. 1039-1091, 2004.
[12] A.R.A. Anderson, M.A.J. Chaplain, E.L. Newman, and R.J.C. Steele, “Mathematical Modelling of Tumour Invasion and Metastasis,” J. Theoretical Medicine, vol. 2, pp. 129-154, 1999.
[13] H.M. Byrne and M.A.J. Chaplain, “Growth of Non-Necrotic Tumours in the Presence and Absence of Inhibitors,” J. Math. Biosciences, vol. 130, pp. 151-181, 1995.
[14] E.D. Angelis and L. Preziosi, “Advection-Diffusion Models for Solid Tumour Evolution in Vivo and Related Free Boundary,” Math. Models and Methods in Applied Sciences, vol. 10, pp. 379-407, 2000.
[15] A.J. Perumpanani and H.M. Byrne, “Extracellular Matrix Concentration Exerts Selection Pressure on Invasive Cells,” J. Cancer, vol. 35, pp. 1274-1280, 1999.
[16] A.R.A. Anderson, “A Hybrid Mathematical Model of Solid Tumour Invasion: The Importance of Cell Adhesion,” Math. Medicine and Biology, vol. 22, pp. 163-186, 2005.
[17] H. Enderling, M. Chaplain, A.R.A. Anderson, and J. Vaidya, “A Mathematical Model of Breast Cancer Development, Local Treatment and Recurrence,” J. Theoretical Biology, vol. 264, pp. 245-259, 2007.
[18] K.R. Swanson, C. Bridge, J.D. Murray, and E.C. Alvord, “Virtual and Real Brain Tumors: Using Mathematical Modeling to Quantify Glioma Growth and Invasion,” J. Neurological Sciences, vol. 216, pp. 1-10, 2003.
[19] A.R.A. Anderson, A.M. Weaver, P.T. Cummings, and V. Quaranta, “Tumor Morphology and Phenotypic Evolution Driven by Selective Pressure from the Microenvironment,” Cell, vol. 127, pp. 905-915, 2006.
[20] K. Smallbone, R.A. Gaten by, R.J. Gillies, P.K. Maini, and D.J. Gavaghan, “Metabolic Changes during Carcinogenesis: Potential Impact on Invasiveness,” J. Theoretical Biology, vol. 244, pp. 703-713, 2007.
[21] A.H. Kyle and A.I. Minchinton, “Measurement of Delivery and Metabolism of Tirapazamine to Tumour Tissue Using the Multilayered Cell Culture Model,” Cancer Chemotherapy and Pharmacology, vol. 43, pp. 213-220, 1988.
[22] K.O. Hicks, F.B. Pruijn, J.R. Sturman, W.A. Denny, W.R. Wilson, B.G. Siim, J.K. Jaiswal, F.B. Pruijn, A.M. Fraser, R. Patel, A. Hogg, H.D.S. Liyanage, M.J. Dorie, J.M. Brown, W.A. Denny, and M.P. Hay, “Pharmacokinetic/Pharmacodynamic Modeling Identifies SN30000 and SN29751 as Tirapazamine Analogues with Improved Tissue Penetration and Hypoxic Cell Killing in Tumors,” Clinical Cancer Research, vol. 16, pp. 4946-4957, 2010.
[23] J. Vohardsky, “Neural Model of the Genetic Network,” J. Biological Chemistry, vol. 276, pp. 36168-36173, 2001.
[24] K. Papik, B. Molnar, R. Schaefer, and Z. Dombovari, “Application of Neural Networks in Medicine- A Review,” Medical Science Monitoring, vol. 4, pp. 538-546, 1998.
[25] K.O. Hicks, S.J. Ohms, P.L.Z. Van, W.A. Danny, P.J. Hunter, and W.R. Wilson, “An Experimental and Mathematical Model for the Extravascular Transport of a DNA Intercalator in Tumours,” J. Cancer, vol. 76, pp. 894-903, 1997.
[26] D.S.M. Cowan, K.O. Hicks, and W.R. Wilson, “Multicellular Membranes as an in Vitro Model for Extravascular Diffusion in Tumours,” J. Cancer, vol. 74, pp. 528-531, 1996.
[27] K.O. Hicks, F.B. Pruijn, J.R. Sturman, W.A. Denny, and W.R. Wilson, “Multicellular Resistance to Tirapazamine is due to Restricted Extravascular Transport: A Pharmacokinetic/Pharmacodynamics Study in HT29 Multicellular Layer Cultures,” Cancer Research, vol. 63, pp. 5970-5977, 2003.
[28] M. Marusic, Z. Bajzer, J.P. Freyer, and S. Vuk-Pavlovic, “Analysis of Growth of Multicellular Tumor Spheroids by Mathematical Models,” Cell Proliferation, vol. 27, pp. 73-94, 1994.
[29] M. Marusic, Z. Bajzer, J.P. Freyer, and S. Vuk-Pavlovic, “Tumor Growth in Vivo and as Multicellular Spheroids Compared by Mathematical Models,” Bull. of Math. Biology, vol. 56, pp. 617-631, 1994.
[30] K. Borkenstein, S. Levegruen, and P. Peschke, “Modeling and Computer Simulation of Tumor Growth and Response to Radiotherapy,” Radiation Research, vol. 162, pp. 71-83, 2004.
[31] P. Gerlee and A.R.A. Anderson, “An Evolutionary Hybrid Cellular Automaton Model of Solid Tumour Growth,” J. Theoretical Biology, vol. 246, pp. 583-603, 2007.
[32] P. Calabresi and P.E. Schein, Medical Oncology, second ed. McGraw-Hill, 1993.
[33] J.P. Freyer and R.M. Sutherland, “Proliferative and Colonogenic Heterogeneity of Cells from EMT6/Ro Multicellular Spheroids Induced by the Glucose and Oxygen Supply,” Cancer Research, vol. 46, pp. 3513-3520, 1986.
[34] J.J. Casciari, S.V. Sotirchos, and R.M. Sutherland, “Variation in Tumour Cell Growth Rates and Metabolism with Oxygen-Concentration, Glucose-Concentration and Extra-Cellular pH,” J. Cell Physiology, vol. 151, pp. 386-394, 1992.
[35] M.T. Leung, W.E. Engeler, P. Frank, and C.R.D Schenectady, “Fingerprint Processing Using Back-Propagation Neuralnetworks,” Proc. Int'l Joint Conf. Neural Networks, vol. 1, pp. 15-20, 1990.
[36] D. Bray, “Intracellular Signaling as a Parallel Distributed Process,” J. Theoretical Biology, vol. 143, pp. 215-231, 1990.
[37] J. Chorowski and J.M. Zurada, “Extracting Rules from Neural Networks as Decision Diagrams,” IEEE Trans. Neural Networks, vol. 99, no. 12 pp. 1-12, Dec. 2011.
[38] I.R. Conde, M.A.J. Chaplain, and A.R.A. Anderson, “Mathematical Modeling of Cancer Cell Invasion of Tissue,” Math. and Computer Modelling, vol. 47, pp. 533-545, 2007.
[39] E. Lartigau and M. Guichard, “Does Tirapazamine (SR-4233) have Any Cytotoxic or Sensitizing Effect on Three Human Tumour Cell Lines at Clinically Relevant Partial Oxygen Pressure?” Int'l J. Radiation Biology, vol. 67, pp. 211-216, 1994.
[40] I.F. Tannock, C.M. Lee, J.K. Tunggal, D.S.M. Cowan, and M.J. Egorin, “Limited Penetration of Anticancer Drugs Through Tumor Tissue: A Potential Cause of Resistance of Solid Tumors to Chemotherapy,” Clinical Cancer Research, vol. 8, pp. 878-884, 2002.
[41] Y. Zheng, “My Notes on Oxygen Concentration in Plasma and Tissue,” Dept. of Psychology, Univ. of Sheffield, United Kingdom, 2011.
[42] J.P. Sutherland, “Role of Necrosis in Regulating the Growth Saturation of Multicellular Spheroids,” Cancer Research, vol. 48, pp. 2432-2439, 1988.
[43] J.P. Freyer and R.M. Sutherland, “Regulation of Growth Saturation and Development of Necrosis in EMT6/Ro Multicellular Spheroids by the Glucose and Oxygen Supply,” Cancer Research, vol. 46, pp. 3513-3520, 1986.
[44] N. Kazmi, M.A. Hossain, and R.M. Phillips, “Intelligent Modeling of Benign Tumour Growth with Cell-Cell and Cell-Matrix Adhesion,” Proc. IEEE 10th Int'l Conf. Computer and Information Technology, 2010.
[45] J. Grote, R. Susskind, and P. Vaupel, “Oxygen Diffusivity in Tumour Tissue (DS-Carcinosarcoma) Under Temperature Conditions Within the Range of 20-40oC,” Pflugers Architecture, vol. 372, pp. 37-42, 1997.
[46] J.J. Casciari, S.V. Sotirchos, and R.M. Sutherland, “Glucose Diffusivity in Multicellular Tumor Spheroids,” Cancer Research, vol. 48, pp. 3905-3909, 1988.
[47] C. Crone and D.G. Levitt, “The Cardiovascular System,” Handbook of Physiology: A Critical Comprehensive Presentation of Physiological Knowledge and Concepts, pp. 434-437, Am. Physiological Soc., 1984.
[48] A. Deutsch and S. Dormann, Cellular Automaton Modeling of Biological Pattern Formation. Birkhäuser, 2005.
[49] W. Düchting and T. Vogelsaenger, “Analysis, Forecasting and Control of Three-Dimensional Tumor Growth and Treatment,” J. Medical Systems, vol. 8, pp. 461-475, 1984.
22 ms
(Ver 2.0)

Marketing Automation Platform Marketing Automation Tool